Chemed Corp
NYSE:CHE
Intrinsic Value
Chemed Corp. engages in the provision of healthcare and maintenance services. [ Read More ]
The intrinsic value of one CHE stock under the Base Case scenario is 472.97 USD. Compared to the current market price of 560.42 USD, Chemed Corp is Overvalued by 16%.
Valuation Backtest
Chemed Corp
Run backtest to discover the historical profit from buying and selling CHE stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Chemed Corp
Current Assets | 500.8m |
Cash & Short-Term Investments | 264m |
Receivables | 181.5m |
Other Current Assets | 55.4m |
Non-Current Assets | 1.2B |
Long-Term Investments | 106.1m |
PP&E | 330.2m |
Intangibles | 675.3m |
Other Non-Current Assets | 55.6m |
Current Liabilities | 312.1m |
Accounts Payable | 48.3m |
Accrued Liabilities | 195.9m |
Short-Term Debt | 15.7m |
Other Current Liabilities | 52.1m |
Non-Current Liabilities | 248.2m |
Other Non-Current Liabilities | 248.2m |
Earnings Waterfall
Chemed Corp
Revenue
|
2.3B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
798.8m
USD
|
Operating Expenses
|
-437.9m
USD
|
Operating Income
|
360.9m
USD
|
Other Expenses
|
-88.4m
USD
|
Net Income
|
272.5m
USD
|
Free Cash Flow Analysis
Chemed Corp
CHE Profitability Score
Profitability Due Diligence
Chemed Corp's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
Score
Chemed Corp's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
CHE Solvency Score
Solvency Due Diligence
Chemed Corp's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Score
Chemed Corp's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CHE Price Targets Summary
Chemed Corp
According to Wall Street analysts, the average 1-year price target for CHE is 703.8 USD with a low forecast of 656.5 USD and a high forecast of 747.6 USD.
Ownership
CHE Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
CHE Price
Chemed Corp
Average Annual Return | 12.6% |
Standard Deviation of Annual Returns | 17.51% |
Max Drawdown | -14% |
Market Capitalization | 8.6B USD |
Shares Outstanding | 15 270 000 |
Percentage of Shares Shorted | 3.44% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Chemed Corp. engages in the provision of healthcare and maintenance services. The company is headquartered in Cincinnati, Ohio and currently employs 14,137 full-time employees. The Company’s segments include VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The firm's VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The firm services are provided through a network of Company-owned branches, independent contractors, and franchisees. The firm operates through its two wholly owned subsidiaries VITAS Healthcare Corporation and Roto-Rooter Group, Inc.
Contact
IPO
Employees
Officers
The intrinsic value of one CHE stock under the Base Case scenario is 472.97 USD.
Compared to the current market price of 560.42 USD, Chemed Corp is Overvalued by 16%.